Global Amantadine HCl Oral Market Research Report 2020


This report focuses on Amantadine HCl Oral volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amantadine HCl Oral market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Zydus Pharmaceuticals
    Mylan
    Teva
    Vertical Pharmaceuticals
    Adamas Pharmaceuticals
    Upsher-Smith
    Sandoz
    Mikart Pharmaceuticals
    Pharmaceutical Associates, Inc. (PAI)
    Wockhardt Bio AG
    CMP Pharma
    Bionpharma
    Graviti Pharma
    Alembic Pharmaceuticals
    Strides Pharma
    Heritage Pharmaceuticals

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Tablet
    Capsules
    Syrup

Segment by Application
    Parkinson's disease
    Influenza
Table of Contents

1 Amantadine HCl Oral Market Overview
    1.1 Product Overview and Scope of Amantadine HCl Oral
    1.2 Amantadine HCl Oral Segment by Type
        1.2.1 Global Amantadine HCl Oral Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 Tablet
        1.2.3 Capsules
        1.2.4 Syrup
    1.3 Amantadine HCl Oral Segment by Application
        1.3.1 Amantadine HCl Oral Sales Comparison by Application: 2020 VS 2026
        1.3.2 Parkinson's disease
        1.3.3 Influenza
    1.4 Global Amantadine HCl Oral Market Size Estimates and Forecasts
        1.4.1 Global Amantadine HCl Oral Revenue 2015-2026
        1.4.2 Global Amantadine HCl Oral Sales 2015-2026
        1.4.3 Amantadine HCl Oral Market Size by Region: 2020 Versus 2026

2 Global Amantadine HCl Oral Market Competition by Manufacturers
    2.1 Global Amantadine HCl Oral Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Amantadine HCl Oral Revenue Share by Manufacturers (2015-2020)
    2.3 Global Amantadine HCl Oral Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Amantadine HCl Oral Manufacturing Sites, Area Served, Product Type
    2.5 Amantadine HCl Oral Market Competitive Situation and Trends
        2.5.1 Amantadine HCl Oral Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Amantadine HCl Oral Players (Opinion Leaders)

3 Amantadine HCl Oral Retrospective Market Scenario by Region
    3.1 Global Amantadine HCl Oral Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Amantadine HCl Oral Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Amantadine HCl Oral Market Facts & Figures by Country
        3.3.1 North America Amantadine HCl Oral Sales by Country
        3.3.2 North America Amantadine HCl Oral Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Amantadine HCl Oral Market Facts & Figures by Country
        3.4.1 Europe Amantadine HCl Oral Sales by Country
        3.4.2 Europe Amantadine HCl Oral Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Amantadine HCl Oral Market Facts & Figures by Region
        3.5.1 Asia Pacific Amantadine HCl Oral Sales by Region
        3.5.2 Asia Pacific Amantadine HCl Oral Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Amantadine HCl Oral Market Facts & Figures by Country
        3.6.1 Latin America Amantadine HCl Oral Sales by Country
        3.6.2 Latin America Amantadine HCl Oral Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Amantadine HCl Oral Market Facts & Figures by Country
        3.7.1 Middle East and Africa Amantadine HCl Oral Sales by Country
        3.7.2 Middle East and Africa Amantadine HCl Oral Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Amantadine HCl Oral Historic Market Analysis by Type
    4.1 Global Amantadine HCl Oral Sales Market Share by Type (2015-2020)
    4.2 Global Amantadine HCl Oral Revenue Market Share by Type (2015-2020)
    4.3 Global Amantadine HCl Oral Price Market Share by Type (2015-2020)
    4.4 Global Amantadine HCl Oral Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Amantadine HCl Oral Historic Market Analysis by Application
    5.1 Global Amantadine HCl Oral Sales Market Share by Application (2015-2020)
    5.2 Global Amantadine HCl Oral Revenue Market Share by Application (2015-2020)
    5.3 Global Amantadine HCl Oral Price by Application (2015-2020)

6 Company Profiles and Key Figures in Amantadine HCl Oral Business
    6.1 Zydus Pharmaceuticals
        6.1.1 Corporation Information
        6.1.2 Zydus Pharmaceuticals Description, Business Overview and Total Revenue
        6.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Zydus Pharmaceuticals Products Offered
        6.1.5 Zydus Pharmaceuticals Recent Development
    6.2 Mylan
        6.2.1 Mylan Amantadine HCl Oral Production Sites and Area Served
        6.2.2 Mylan Description, Business Overview and Total Revenue
        6.2.3 Mylan Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Mylan Products Offered
        6.2.5 Mylan Recent Development
    6.3 Teva
        6.3.1 Teva Amantadine HCl Oral Production Sites and Area Served
        6.3.2 Teva Description, Business Overview and Total Revenue
        6.3.3 Teva Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Teva Products Offered
        6.3.5 Teva Recent Development
    6.4 Vertical Pharmaceuticals
        6.4.1 Vertical Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
        6.4.2 Vertical Pharmaceuticals Description, Business Overview and Total Revenue
        6.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Vertical Pharmaceuticals Products Offered
        6.4.5 Vertical Pharmaceuticals Recent Development
    6.5 Adamas Pharmaceuticals
        6.5.1 Adamas Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
        6.5.2 Adamas Pharmaceuticals Description, Business Overview and Total Revenue
        6.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Adamas Pharmaceuticals Products Offered
        6.5.5 Adamas Pharmaceuticals Recent Development
    6.6 Upsher-Smith
        6.6.1 Upsher-Smith Amantadine HCl Oral Production Sites and Area Served
        6.6.2 Upsher-Smith Description, Business Overview and Total Revenue
        6.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Upsher-Smith Products Offered
        6.6.5 Upsher-Smith Recent Development
    6.7 Sandoz
        6.6.1 Sandoz Amantadine HCl Oral Production Sites and Area Served
        6.6.2 Sandoz Description, Business Overview and Total Revenue
        6.6.3 Sandoz Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Sandoz Products Offered
        6.7.5 Sandoz Recent Development
    6.8 Mikart Pharmaceuticals
        6.8.1 Mikart Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
        6.8.2 Mikart Pharmaceuticals Description, Business Overview and Total Revenue
        6.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 Mikart Pharmaceuticals Products Offered
        6.8.5 Mikart Pharmaceuticals Recent Development
    6.9 Pharmaceutical Associates, Inc. (PAI)
        6.9.1 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Production Sites and Area Served
        6.9.2 Pharmaceutical Associates, Inc. (PAI) Description, Business Overview and Total Revenue
        6.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 Pharmaceutical Associates, Inc. (PAI) Products Offered
        6.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Development
    6.10 Wockhardt Bio AG
        6.10.1 Wockhardt Bio AG Amantadine HCl Oral Production Sites and Area Served
        6.10.2 Wockhardt Bio AG Description, Business Overview and Total Revenue
        6.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.10.4 Wockhardt Bio AG Products Offered
        6.10.5 Wockhardt Bio AG Recent Development
    6.11 CMP Pharma
        6.11.1 CMP Pharma Amantadine HCl Oral Production Sites and Area Served
        6.11.2 CMP Pharma Amantadine HCl Oral Description, Business Overview and Total Revenue
        6.11.3 CMP Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.11.4 CMP Pharma Products Offered
        6.11.5 CMP Pharma Recent Development
    6.12 Bionpharma
        6.12.1 Bionpharma Amantadine HCl Oral Production Sites and Area Served
        6.12.2 Bionpharma Amantadine HCl Oral Description, Business Overview and Total Revenue
        6.12.3 Bionpharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.12.4 Bionpharma Products Offered
        6.12.5 Bionpharma Recent Development
    6.13 Graviti Pharma
        6.13.1 Graviti Pharma Amantadine HCl Oral Production Sites and Area Served
        6.13.2 Graviti Pharma Amantadine HCl Oral Description, Business Overview and Total Revenue
        6.13.3 Graviti Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.13.4 Graviti Pharma Products Offered
        6.13.5 Graviti Pharma Recent Development
    6.14 Alembic Pharmaceuticals
        6.14.1 Alembic Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
        6.14.2 Alembic Pharmaceuticals Amantadine HCl Oral Description, Business Overview and Total Revenue
        6.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.14.4 Alembic Pharmaceuticals Products Offered
        6.14.5 Alembic Pharmaceuticals Recent Development
    6.15 Strides Pharma
        6.15.1 Strides Pharma Amantadine HCl Oral Production Sites and Area Served
        6.15.2 Strides Pharma Amantadine HCl Oral Description, Business Overview and Total Revenue
        6.15.3 Strides Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.15.4 Strides Pharma Products Offered
        6.15.5 Strides Pharma Recent Development
    6.16 Heritage Pharmaceuticals
        6.16.1 Heritage Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
        6.16.2 Heritage Pharmaceuticals Amantadine HCl Oral Description, Business Overview and Total Revenue
        6.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2015-2020)
        6.16.4 Heritage Pharmaceuticals Products Offered
        6.16.5 Heritage Pharmaceuticals Recent Development

7 Amantadine HCl Oral Manufacturing Cost Analysis
    7.1 Amantadine HCl Oral Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Amantadine HCl Oral
    7.4 Amantadine HCl Oral Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Amantadine HCl Oral Distributors List
    8.3 Amantadine HCl Oral Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Amantadine HCl Oral Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Amantadine HCl Oral by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Amantadine HCl Oral by Type (2021-2026)
    10.2 Amantadine HCl Oral Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Amantadine HCl Oral by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Amantadine HCl Oral by Application (2021-2026)
    10.3 Amantadine HCl Oral Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Amantadine HCl Oral by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Amantadine HCl Oral by Region (2021-2026)
    10.4 North America Amantadine HCl Oral Estimates and Projections (2021-2026)
    10.5 Europe Amantadine HCl Oral Estimates and Projections (2021-2026)
    10.6 Asia Pacific Amantadine HCl Oral Estimates and Projections (2021-2026)
    10.7 Latin America Amantadine HCl Oral Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Amantadine HCl Oral Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Amantadine HCl Oral Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Amantadine HCl Oral Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Amantadine HCl Oral Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Amantadine HCl Oral Manufacturers Covered in This Study Table 5. Global Amantadine HCl Oral Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Amantadine HCl Oral Sales Share by Manufacturers (2015-2020) Table 7. Global Amantadine HCl Oral Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Amantadine HCl Oral Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Amantadine HCl Oral Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Amantadine HCl Oral Sales Sites and Area Served Table 11. Manufacturers Amantadine HCl Oral Product Types Table 12. Global Amantadine HCl Oral Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Amantadine HCl Oral by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amantadine HCl Oral as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Amantadine HCl Oral Players Table 16. Global Amantadine HCl Oral Sales (K MT) by Region (2015-2020) Table 17. Global Amantadine HCl Oral Sales Market Share by Region (2015-2020) Table 18. Global Amantadine HCl Oral Revenue (Million US$) by Region (2015-2020) Table 19. Global Amantadine HCl Oral Revenue Market Share by Region (2015-2020) Table 20. North America Amantadine HCl Oral Sales by Country (2015-2020) (K MT) Table 21. North America Amantadine HCl Oral Sales Market Share by Country (2015-2020) Table 22. North America Amantadine HCl Oral Revenue by Country (2015-2020) (US$ Million) Table 23. North America Amantadine HCl Oral Revenue Market Share by Country (2015-2020) Table 24. Europe Amantadine HCl Oral Sales by Country (2015-2020) (K MT) Table 25. Europe Amantadine HCl Oral Sales Market Share by Country (2015-2020) Table 26. Europe Amantadine HCl Oral Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Amantadine HCl Oral Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Amantadine HCl Oral Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Amantadine HCl Oral Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Amantadine HCl Oral Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Amantadine HCl Oral Revenue Market Share by Region (2015-2020) Table 32. Latin America Amantadine HCl Oral Sales by Country (2015-2020) (K MT) Table 33. Latin America Amantadine HCl Oral Sales Market Share by Country (2015-2020) Table 34. Latin America Amantadine HCl Oral Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Amantadine HCl Oral Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Amantadine HCl Oral Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Amantadine HCl Oral Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Amantadine HCl Oral Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Amantadine HCl Oral Revenue Market Share by Country (2015-2020) Table 40. Global Amantadine HCl Oral Sales (K MT) by Type (2015-2020) Table 41. Global Amantadine HCl Oral Sales Share by Type (2015-2020) Table 42. Global Amantadine HCl Oral Revenue (Million US$) by Type (2015-2020) Table 43. Global Amantadine HCl Oral Revenue Share by Type (2015-2020) Table 44. Global Amantadine HCl Oral Price (USD/MT) by Type (2015-2020) Table 45. Global Amantadine HCl Oral Sales (K MT) by Application (2015-2020) Table 46. Global Amantadine HCl Oral Sales Market Share by Application (2015-2020) Table 47. Global Amantadine HCl Oral Sales Growth Rate by Application (2015-2020) Table 48. Zydus Pharmaceuticals Amantadine HCl Oral Corporation Information Table 49. Zydus Pharmaceuticals Description and Business Overview Table 50. Zydus Pharmaceuticals Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Zydus Pharmaceuticals Main Product Table 52. Zydus Pharmaceuticals Recent Development Table 53. Mylan Amantadine HCl Oral Corporation Information Table 54. Mylan Corporation Information Table 55. Mylan Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Mylan Main Product Table 57. Mylan Recent Development Table 58. Teva Amantadine HCl Oral Corporation Information Table 59. Teva Corporation Information Table 60. Teva Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Teva Main Product Table 62. Teva Recent Development Table 63. Vertical Pharmaceuticals Amantadine HCl Oral Corporation Information Table 64. Vertical Pharmaceuticals Corporation Information Table 65. Vertical Pharmaceuticals Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Vertical Pharmaceuticals Main Product Table 67. Vertical Pharmaceuticals Recent Development Table 68. Adamas Pharmaceuticals Amantadine HCl Oral Corporation Information Table 69. Adamas Pharmaceuticals Corporation Information Table 70. Adamas Pharmaceuticals Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Adamas Pharmaceuticals Main Product Table 72. Adamas Pharmaceuticals Recent Development Table 73. Upsher-Smith Amantadine HCl Oral Corporation Information Table 74. Upsher-Smith Corporation Information Table 75. Upsher-Smith Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Upsher-Smith Main Product Table 77. Upsher-Smith Recent Development Table 78. Sandoz Amantadine HCl Oral Corporation Information Table 79. Sandoz Corporation Information Table 80. Sandoz Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Sandoz Main Product Table 82. Sandoz Recent Development Table 83. Mikart Pharmaceuticals Amantadine HCl Oral Corporation Information Table 84. Mikart Pharmaceuticals Corporation Information Table 85. Mikart Pharmaceuticals Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Mikart Pharmaceuticals Main Product Table 87. Mikart Pharmaceuticals Recent Development Table 88. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Corporation Information Table 89. Pharmaceutical Associates, Inc. (PAI) Corporation Information Table 90. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Pharmaceutical Associates, Inc. (PAI) Main Product Table 92. Pharmaceutical Associates, Inc. (PAI) Recent Development Table 93. Wockhardt Bio AG Amantadine HCl Oral Corporation Information Table 94. Wockhardt Bio AG Corporation Information Table 95. Wockhardt Bio AG Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Wockhardt Bio AG Main Product Table 97. Wockhardt Bio AG Recent Development Table 98. CMP Pharma Amantadine HCl Oral Corporation Information Table 99. CMP Pharma Corporation Information Table 100. CMP Pharma Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. CMP Pharma Main Product Table 102. CMP Pharma Recent Development Table 103. Bionpharma Amantadine HCl Oral Corporation Information Table 104. Bionpharma Corporation Information Table 105. Bionpharma Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. Bionpharma Main Product Table 107. Bionpharma Recent Development Table 108. Graviti Pharma Amantadine HCl Oral Corporation Information Table 109. Graviti Pharma Corporation Information Table 110. Graviti Pharma Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Graviti Pharma Main Product Table 112. Graviti Pharma Recent Development Table 113. Alembic Pharmaceuticals Amantadine HCl Oral Corporation Information Table 114. Alembic Pharmaceuticals Corporation Information Table 115. Alembic Pharmaceuticals Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 116. Alembic Pharmaceuticals Main Product Table 117. Alembic Pharmaceuticals Recent Development Table 118. Strides Pharma Amantadine HCl Oral Corporation Information Table 119. Strides Pharma Corporation Information Table 120. Strides Pharma Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 121. Strides Pharma Main Product Table 122. Strides Pharma Recent Development Table 123. Heritage Pharmaceuticals Amantadine HCl Oral Corporation Information Table 124. Heritage Pharmaceuticals Corporation Information Table 125. Heritage Pharmaceuticals Amantadine HCl Oral Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 126. Heritage Pharmaceuticals Main Product Table 127. Heritage Pharmaceuticals Recent Development Table 128. Sales Base and Market Concentration Rate of Raw Material Table 129. Key Suppliers of Raw Materials Table 130. Amantadine HCl Oral Distributors List Table 131. Amantadine HCl Oral Customers List Table 132. Market Key Trends Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 134. Key Challenges Table 135. Global Amantadine HCl Oral Sales (K MT) Forecast by Type (2021-2026) Table 136. Global Amantadine HCl Oral Sales Market Share Forecast by Type (2021-2026) Table 137. Global Amantadine HCl Oral Revenue (Million US$) Forecast by Type (2021-2026) Table 138. Global Amantadine HCl Oral Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 139. Global Amantadine HCl Oral Sales (K MT) Forecast by Application (2021-2026) Table 140. Global Amantadine HCl Oral Revenue (Million US$) Forecast by Application (2021-2026) Table 141. Global Amantadine HCl Oral Sales (K MT) Forecast by Region (2021-2026) Table 142. Global Amantadine HCl Oral Sales Market Share Forecast by Region (2021-2026) Table 143. Global Amantadine HCl Oral Revenue Forecast by Region (2021-2026) (US$ Million) Table 144. Global Amantadine HCl Oral Revenue Market Share Forecast by Region (2021-2026) Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Amantadine HCl Oral Figure 2. Global Amantadine HCl Oral Sales Market Share by Type: 2020 VS 2026 Figure 3. Tablet Product Picture Figure 4. Capsules Product Picture Figure 5. Syrup Product Picture Figure 6. Global Amantadine HCl Oral Consumption Market Share by Application: 2020 VS 2026 Figure 7. Parkinson's disease Figure 8. Influenza Figure 9. Global Amantadine HCl Oral Market Size 2015-2026 (US$ Million) Figure 10. Global Amantadine HCl Oral Sales Capacity (K MT) (2015-2026) Figure 11. Global Amantadine HCl Oral Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Amantadine HCl Oral Sales Share by Manufacturers in 2020 Figure 13. Global Amantadine HCl Oral Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Amantadine HCl Oral Revenue in 2019 Figure 15. Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Amantadine HCl Oral Sales Market Share by Region (2015-2020) Figure 17. Global Amantadine HCl Oral Sales Market Share by Region in 2019 Figure 18. Global Amantadine HCl Oral Revenue Market Share by Region (2015-2020) Figure 19. Global Amantadine HCl Oral Revenue Market Share by Region in 2019 Figure 20. North America Amantadine HCl Oral Sales Market Share by Country in 2019 Figure 21. North America Amantadine HCl Oral Revenue Market Share by Country in 2019 Figure 22. U.S. Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 23. U.S. Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 25. Canada Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Amantadine HCl Oral Sales Market Share by Country in 2019 Figure 27. Europe Amantadine HCl Oral Revenue Market Share by Country in 2019 Figure 28. Germany Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 29. Germany Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 31. France Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 33. U.K. Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 35. Italy Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 37. Russia Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Amantadine HCl Oral Sales Market Share by Region in 2019 Figure 39. Asia Pacific Amantadine HCl Oral Revenue Market Share by Region in 2019 Figure 40. China Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 41. China Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 43. Japan Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 45. South Korea Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 47. India Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 49. Australia Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 51. Taiwan Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 53. Indonesia Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 55. Thailand Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 57. Malaysia Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 59. Philippines Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 61. Vietnam Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Amantadine HCl Oral Sales Market Share by Country in 2019 Figure 63. Latin America Amantadine HCl Oral Revenue Market Share by Country in 2019 Figure 64. Mexico Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 65. Mexico Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 67. Brazil Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 69. Argentina Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Amantadine HCl Oral Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Amantadine HCl Oral Revenue Market Share by Country in 2019 Figure 72. Turkey Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 73. Turkey Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 75. Saudi Arabia Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Amantadine HCl Oral Sales Growth Rate (2015-2020) (K MT) Figure 77. U.A.E Amantadine HCl Oral Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Amantadine HCl Oral by Type (2015-2020) Figure 79. Sales Market Share of Amantadine HCl Oral by Type in 2019 Figure 80. Revenue Share of Amantadine HCl Oral by Type (2015-2020) Figure 81. Revenue Market Share of Amantadine HCl Oral by Type in 2019 Figure 82. Global Amantadine HCl Oral Sales Growth by Type (2015-2020) (K MT) Figure 83. Global Amantadine HCl Oral Sales Market Share by Application (2015-2020) Figure 84. Global Amantadine HCl Oral Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Amantadine HCl Oral by Application (2015-2020) Figure 86. Global Revenue Share of Amantadine HCl Oral by Application in 2020 Figure 87. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Vertical Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Adamas Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Upsher-Smith Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Mikart Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Pharmaceutical Associates, Inc. (PAI) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Wockhardt Bio AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. CMP Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Bionpharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Graviti Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Alembic Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Strides Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Heritage Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Price Trend of Key Raw Materials Figure 104. Manufacturing Cost Structure of Amantadine HCl Oral Figure 105. Manufacturing Process Analysis of Amantadine HCl Oral Figure 106. Amantadine HCl Oral Industrial Chain Analysis Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Porter's Five Forces Analysis Figure 110. North America Amantadine HCl Oral Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 111. North America Amantadine HCl Oral Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Europe Amantadine HCl Oral Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. Europe Amantadine HCl Oral Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Latin America Amantadine HCl Oral Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. Latin America Amantadine HCl Oral Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Middle East and Africa Amantadine HCl Oral Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Middle East and Africa Amantadine HCl Oral Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Asia Pacific Amantadine HCl Oral Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 119. Asia Pacific Amantadine HCl Oral Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global Vinyl Versatate Market Professional Survey Report 2020

The global Vinyl Versatate market was valued at US$ 328.37 million in 2019 and will reach US$ 639.42 million by the end of 2026, growing at a CAGR of 9.75% during 2021-2026. This report focuses on Vinyl Versatate volume and value at the global level,...

Global Refrigerated Containers Market Report, History and Forecast 2015-2026

Market Analysis and Insights: Global Refrigerated Containers Market In 2019, the global Refrigerated Containers market size was US$ 1376.17 million and it is expected to reach US$ 1973.42 million by the end of 2026, with a CAGR of 5.52% between 2020 ...

Global Medium-density Fiberboard Market Research Report 2020

Market Analysis and Insights: Global Medium-density Fiberboard Market The global Medium-density Fiberboard market is valued at US$ 28473.08 million in 2019 and is expected to reach US$ 41016.95 million by the end of 2027, growing at a CAGR of 4.59% d...

Global Low Voltage DC Circuit Breaker Market Professional Survey Report 2020

The global Low Voltage DC Circuit Breaker market was valued at 1237.26 million US$ in 2019 and will reach 1816.27 million US$ by the end of 2026, growing at a CAGR of 5.65% during 2020-2026. This report focuses on Low Voltage DC Circuit Breaker volum...

Global Glass Nonwovens Wet-Laid Industry Research Report Growth Trends and Competitive Analysis 2020-2026

Market Overview The Glass Nonwovens Wet-Laid market was valued at US$ 1246 million in 2019 and is projected to reach US$ 1605 million by 2026, at a CAGR of 3.68% during the forecast period. In this study, 2018 has been considered as the base year and...

Publisher: QY Research